Search company, investor...

InnaPhase Corporation

Founded Year



Acquired | Acquired

Total Raised




About InnaPhase Corporation

InnaPHase is a provider of Laboratory Information Management Systems (LIMS) solutions dedicated to the pharmaceutical industry. The company's 21 CFR Part 11 compliant LIMS suite includes solutions for: analytical development quality control and stability testing; for DMPK/Bioanalytical studies in drug development; and for In Vitro testing. InnaPhase was acquired by Thermo Electron (NYSE: TMO) in September 2004.

Headquarters Location

1601 Cherry Street Suite 1200

Philadelphia, Pennsylvania, 19102,

United States


Missing: InnaPhase Corporation's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: InnaPhase Corporation's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

InnaPhase Corporation Frequently Asked Questions (FAQ)

  • When was InnaPhase Corporation founded?

    InnaPhase Corporation was founded in 1998.

  • Where is InnaPhase Corporation's headquarters?

    InnaPhase Corporation's headquarters is located at 1601 Cherry Street, Philadelphia.

  • What is InnaPhase Corporation's latest funding round?

    InnaPhase Corporation's latest funding round is Acquired.

  • How much did InnaPhase Corporation raise?

    InnaPhase Corporation raised a total of $13.45M.

  • Who are the investors of InnaPhase Corporation?

    Investors of InnaPhase Corporation include Thermo Electron, Edison Partners, EuclidSR Partners, LLR Partners and NewSpring Capital.

  • Who are InnaPhase Corporation's competitors?

    Competitors of InnaPhase Corporation include Austrianova, ArisGlobal, PHT Corporation, Octagon Research Solutions, Advion Bioanalytical Labs and 12 more.

Compare InnaPhase Corporation to Competitors

NCI Cancer Hospital

NCI Cancer Hospital is a private oncology centre in Malaysia that combines treatment and clinical research. NCI aims to provide a range of services from diagnosis, laboratory analysis, surgery, chemotherapy and radiotherapy. It operates to GCP and has conducted clinical trials for a number of pharmaceutical companies including Roche, BMS and AstraZeneca.


Micromyx is a microbiology services company engaged in anti-infective discovery and development for the pharmaceutical, biotechnology, and animal health industries. Founded in 2004 by former pharmaceutical industry infectious disease scientists, Micromyx is a contract research organization that aims to offer clients documented, top-of-the-line laboratory services from experts who have successfully gained FDA approval of new antibiotics.

Sai Life Sciences Logo
Sai Life Sciences

Sai Life Sciences offers their clients a wide range of integrated drug discovery, development and formulation services, with core expertise founded in synthetic, medicinal and process chemistry and further augmented by a suite of preclinical support services including DMPK, toxicology and formulation that are continually expanding to meet clients' needs.

Micro Measurement Laboratories

Micro Measurement Laboratories, Inc. is an independent contract testing laboratory engaged in the application and research of measuring particles and their affects on materials and processes.


C-TASC (Clinical Trials & Surveys Corporation) was founded in 1989 to coordinate, manage, and provide statistical support for clinical trials and observational studies. C-TASC is a 100% employee owned business which completed a management-led buyout in 2004 from its parent company. C-TASC conducts clinical trials, cohort studies, cross-sectional studies and case-control studies.

Progenix Research

Progenix Research is an independent contract research organisation offering toxicology services to the world-wide pharmaceutical, biotechnology, agrochemical and industrial chemical industries. It is a newly formed, independent contract research organisation with laboratory facilities currently under construction in Penang, Malaysia. The company's European headquarters are based in Malvern, England, and it also has a histopathology laboratory in Edinburgh, Scotland. A high quality, yet cost-efficient service for toxicology and associated studies will be offered, including studies on pharmaceuticals, biotechnology products, medical devices, food additives, agrochemicals, biocides, and speciality chemicals.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.